Pharmacy Times spoke with Chad Landon, attorney and chair of Axinn's Intellectual Property and FDA Practice Groups, about key events in the FDA pipeline, such as Emergency Use Authorizations during COVID-19 and the future of narrowed approvals.
London went into further detail on upcoming clinical trials on COVID-19 booster shots, the possibility of cancer vaccines, and the future of pharmaceuticals and FDA approvals.
Link to Pharmacy Times for more pharmacy news!
https://www.pharmacytimes.com/